Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone addition vs oxycodone dose escalation for refractory cancer pain (feasibility RCT)
jRCTs031240220Recruiting
- Sponsor
- GRASP
- Start
- Jul 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in cancer pain comparing Methadone addition arm with Oxycodone dose escalation arm (2 arms). Primary endpoint: Two-week study treatment completion rate. Started Jul 2024; status: recruiting.
02
Drugs
methadoneoxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on jRCTs031240220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240220.